卫宁健康
(300253)
| 流通市值：182.67亿 | | | 总市值：211.30亿 |
| 流通股本：19.13亿 | | | 总股本：22.13亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 344,975,742.42 | 2,782,240,900.17 | 1,913,315,732.46 | 1,223,742,976.83 |
| 营业收入 | 344,975,742.42 | 2,782,240,900.17 | 1,913,315,732.46 | 1,223,742,976.83 |
| 二、营业总成本 | 379,819,298.28 | 2,513,175,392.73 | 1,775,372,358.9 | 1,158,172,450.36 |
| 营业成本 | 226,094,496.62 | 1,622,614,592.4 | 1,128,086,329.35 | 717,727,313.69 |
| 税金及附加 | 3,490,001.09 | 23,120,416.78 | 14,583,932.94 | 10,067,015.13 |
| 销售费用 | 51,624,011.54 | 342,989,824.89 | 240,620,283.19 | 166,899,882.19 |
| 管理费用 | 31,829,859.89 | 202,378,956.38 | 140,458,898.95 | 97,842,079.98 |
| 研发费用 | 51,230,601.51 | 264,630,454.46 | 209,221,376.53 | 137,369,566.7 |
| 财务费用 | 15,550,327.63 | 57,441,147.82 | 42,401,537.94 | 28,266,592.67 |
| 其中:利息费用 | 16,839,511.62 | 66,760,949.12 | 50,453,808.49 | 33,538,244.16 |
| 其中:利息收入 | 1,394,476.79 | 10,140,083.31 | 8,626,552.12 | 6,144,582.72 |
| 加:公允价值变动收益 | -466,173.99 | -28,587,504.56 | 4,887,217.86 | 6,961,257.11 |
| 加:投资收益 | -6,602,627.9 | -48,245,970.27 | -30,010,311.4 | -20,894,459.16 |
| 资产处置收益 | 2,869.53 | -279,415.72 | 178,476.75 | 174,975.76 |
| 资产减值损失(新) | -23,926,048.86 | -169,314,950.48 | -64,330,256.79 | -77,389,416.55 |
| 信用减值损失(新) | 44,436,078.58 | -86,301,660.34 | -7,499,818.52 | -6,546,213.76 |
| 其他收益 | 21,786,778.28 | 150,836,792.72 | 83,237,076.67 | 49,456,737.59 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 387,319.78 | 87,172,798.79 | 124,405,758.13 | 17,333,407.46 |
| 加:营业外收入 | 10,116.06 | 363,922.2 | 32,354.79 | 7,257.09 |
| 减:营业外支出 | 1,004,636.21 | 577,394.55 | 545,382.11 | 225,981.69 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -607,200.37 | 86,959,326.44 | 123,892,730.81 | 17,114,682.86 |
| 减:所得税费用 | 2,737,800.91 | 36,891,687.18 | -13,551,055.98 | -5,099,392.55 |
| 六、净利润 | -3,345,001.28 | 50,067,639.26 | 137,443,786.79 | 22,214,075.41 |
| 持续经营净利润 | -3,345,001.28 | 50,067,639.26 | 137,443,786.79 | 22,214,075.41 |
| 归属于母公司股东的净利润 | 5,289,433.21 | 87,893,175.35 | 154,630,806.68 | 30,168,354.32 |
| 少数股东损益 | -8,634,434.49 | -37,825,536.09 | -17,187,019.89 | -7,954,278.91 |
| (一)基本每股收益 | 0 | 0.04 | 0.07 | 0.01 |
| (二)稀释每股收益 | 0 | 0.04 | 0.07 | 0.01 |
| 九、综合收益总额 | -3,345,001.28 | 50,067,639.26 | 137,443,786.79 | 22,214,075.41 |
| 归属于母公司股东的综合收益总额 | 5,289,433.21 | 87,893,175.35 | 154,630,806.68 | 30,168,354.32 |
| 归属于少数股东的综合收益总额 | -8,634,434.49 | -37,825,536.09 | -17,187,019.89 | -7,954,278.91 |
| 公告日期 | 2025-04-25 | 2025-04-19 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |